2025 Symposium Supporters


Premier Level Supporters

Alexandria


Gold Level Supporters

BostonGene

Bristol Myers Squibb

Foundation Medicine

Inhibrx

LifeSci Communications

Lilly

Varian, a Siemens Healthineers Company


Silver Level Supporters

Johnson & Johnson

Novartis


Bronze Level Supporters

Avalon BioVentures

Cardiff Oncology

Caris Life Sciences

Crown Bioscience

Exelixis

Susan and David KABAKOFF

Kura Oncology

Lantheus

Natera

Neomorph

Pfizer

Radformation

Z-Alpha

Anonymous


Supporters

Alkyon Therapeutics

Ionis Pharmaceuticals

Monoceros Biosystems

Treeline Biosciences

Yatiri Bio

Potential Supporters

If you would like to support the 2025 Symposium, please contact Ida at ideichaite@ucsd.edu.

Special Thanks to our Past Supporters

The Symposium would not be possible without support from the San Diego ecosystem and biotech community.

We share a heartfelt thanks to our past supporters: 2024 Supporters (PDF) | 2023 Supporters (PDF)


COI Policy: Disclosure of Relationships with Companies

The Symposium strives for independence, objectivity, transparency, and scientific rigor in all its activities through appropriate disclosure and management of financial relationships, among other things. The Symposium Policy for Relationships with Companies (COI Policy), in compliance with UC San Diego and University of California Office of the President (UCOP) COI policies (available at this link), was developed to help guide the management of potential conflicts, primarily through disclosure of all financial relationships that might result in actual, potential, or perceived conflicts of interest.

The Symposium requires participants in its activities—and all faculty and committee members— to disclose all of their financial relationships with for-profit health care companies. The Symposium’s Policy is not intended to create a presumption of impropriety based on the existence of financial relationships with companies, rather the goal is to achieve full transparency through the disclosure of those relationships. Although the Symposium Policy relies primarily on disclosure of financial relationships, it also recognizes that some relationships cannot be managed with disclosure alone and identifies additional management steps in this case.

The Symposium wants to help participants in its activities to successfully report their disclosures. To that end, the Symposium uses a general disclosure model, requiring disclosure of all relationships.